EGFR and glioma: The lifting of PRC2-mediated repression unleashes a cascade of pro-tumorigenic events: formerly silenced oncogenic factors become active, which in turn drive the formation of glioma-specific super-enhancers and up-regulate oncogenes such as EGFR, miR-21, and WEE1 [17].